Correction to: Letter to the Editor-Recent advances in Lynch syndrome.

Møller, Pål; Sampson, Julian; Dominguez-Valentin, Mev; Burn, John; Sunde, Lone; Möslein, Gabriela; Mecklin, Jukka-Pekka; Seppälä, Toni.

Afiliação

Møller P; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. moller.pal@gmail.com.
Sampson J; Division of Cancer and Genetics, Institute of Medical Genetics, Cardiff University School of Medicine, Cardiff, UK.
Dominguez-Valentin M; Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Burn J; Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Sunde L; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Möslein G; Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Mecklin JP; Center for Hereditary Tumors, University Witten/ Herdecke, Ev. Bethesda Khs zu Duisburg, Witten, Germany.
Seppälä T; Department of Surgery, Central Finland Health Care District, and Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.

Fam Cancer ; 20(2): 119, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33792829

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article